Special Issue Item
Scientific opinions of Scientific/Scientific Panel
Opinion of the Scientific Committee/Scientific Panel
Statement of the Scientific Committee/Scientific Panel
Guidance of the Scientific Committee/Scientific Panel
Statement of EFSA
Guidance of EFSA
Conclusion on pesticides
Reasoned opinion on pesticide
Scientific report of EFSA
Animal health & welfare
Dietary & chemical monitoring
Assessment and methodological support
Statement of EFSA on a study associating bisphenol A with medical disorders
No abstract available
The European Food Safety Authority (EFSA) received a request on 29 September 2008 from the European Commission requesting an assessment of the implications to the hazard and risk assessment of bisphenol A (BPA) of a study published in the Journal of the American Medical Association (JAMA) on 16 September (Lang et al., 2008), correlating urinary BPA concentrations to medical disorders in adults.
The former EFSA Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) carried out a comprehensive risk assessment on bisphenol A (BPA) in 2006 and set a full Tolerable Daily Intake (TDI) of 0.05 mg/kg body weight (bw)/day.
EFSA concluded that this single study does not provide sufficient proof for a causal link between exposure to BPA and the health conditions mentioned in the study, i.e. heart disease, diabetes and elevated liver-enzyme activities. Therefore, EFSA considers that there is no need to revise the TDI as derived by the AFC Panel in 2006.
Bisphenol A, CAS no. 80-05-7, cardiovascular disease, diabetes, liver-enzyme abnormalities